// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Incidence of Extra-Articular Manifestations in Psa and As Patients Treated with Golimumab in Canadian Real-World

Michelle Teo - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

Ustekinumab

Incidence of Hip Fracture in Rheumatoid Arthritis: British Columbia, Canada

C. Allyson Jones - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Incidence of Infections in Early Arthritis

Meriem Kerbachi - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Incidence of Infusion Reactions to Intravenous Golimumab: Results from a Prospective, Real-World Community Registry

Rafat Faraawi - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

golimumab

Increasing Population Burden of Psoriatic Disease in Ontario, Canada – a Longitudinal Cohort Study

Lihi Eder - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Incremental Direct Medical Costs of Systemic Lupus Erythematosus Patients in the Years Preceding Diagnosis and the Impact of Sex: A General Population-Based Study

Natalie McCormick - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Indications for Cesarean Delivery in Systemic Lupus Erythematosus Pregnancies

Evelyne Vinet - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Indications for Initial Renal Biopsy in Systemic Lupus Erythematosus: A Systematic Review of the Literature

Andrew McKinnon - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Individualized Prediction of Early Remission on Medication in Juvenile Idiopathic Arthritis

Jaime Guzman - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Infectious Complications in Systemic Necrotizing Vasculitides: Pooled Analysis of Five Prospective, Randomized, Controlled Trials

Lafarge Antoine - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Integrated Efficacy Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis

Peter Nash - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Tasocitinib

Integrated Phase 3 Safety Results of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis

Daniel Aletaha - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

sirukumab

Interferon-Alpha Disrupts Tolerance in a Mouse Model of B Cell Anergy

Dario Ferri - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interferon alpha

International League of Associations for Rheumatology. Systematic Review of the Literature to Inform Treatment Recommendations for Psoriatic Arthritis in Resource-Poor Countries

Musaab Elmamoun - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Dermatology

N/A

N/A

Investigating Time Trends in Incident Pediatric Lupus across Ethnic Groups in Toronto, Canada—a Large, Multiethnic Metropolitan Area

Laura Y Feldman - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

iRhom2 Deficiency Protects Fcgr2b-/- Lupus-Prone Mice from Kidney Damage By Modulating ADAM17-Dependent Shedding of TNF-α and EGFR Ligand

Xiaoping Qing - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

L-Tyrosine

Is Earlier Golimumab Treatment Initiation in Psa and As Patients Associated with Improved Outcomes?

Suneil Kapur - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Ustekinumab

Ixekizumab Improves Patient-Reported Outcomes through 52 Weeks in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to Tumor Necrosis Factor-Inhibitors

Arthur Kavanaugh - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Dermatology

N/A

LY2439821

Joint Injection Practices in Pediatric Rheumatology – Preliminary Data from an Ongoing Web Based Survey

Anita Dhanrajani - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Juvenile-Onset Ankylosing Spondylitis Has a Lower Rate of Radiographic Progression Than Adult-Onset Ankylosing Spondylitis

Anthony So - American College of Rheumatology (ACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved